Penn Medicine Abramson Cancer Center


 

ASH 2019 Update on New Therapies for Relapsed Myeloma: Daratumumab, Selinexor + Pom/dex & Investigational Combinations With Venetoclax

38 views
February 24, 2020
Comments 0
Login to view comments. Click here to Login